484 related articles for article (PubMed ID: 33743635)
1. PCNA-associated factor (KIAA0101/PCLAF) overexpression and gene copy number alterations in hepatocellular carcinoma tissues.
Tantiwetrueangdet A; Panvichian R; Sornmayura P; Leelaudomlipi S; Macoska JA
BMC Cancer; 2021 Mar; 21(1):295. PubMed ID: 33743635
[TBL] [Abstract][Full Text] [Related]
2. Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activation.
Liu L; Chen X; Xie S; Zhang C; Qiu Z; Zhu F
Hepatology; 2012 Nov; 56(5):1760-9. PubMed ID: 22576474
[TBL] [Abstract][Full Text] [Related]
3. KIAA0101 mRNA expression in the peripheral blood of hepatocellular carcinoma patients: Association with some clinicopathological features.
Abdelgawad IA; Radwan NH; Hassanein HR
Clin Biochem; 2016 Jul; 49(10-11):787-91. PubMed ID: 26968109
[TBL] [Abstract][Full Text] [Related]
4. TOP2A amplification and overexpression in hepatocellular carcinoma tissues.
Panvichian R; Tantiwetrueangdet A; Angkathunyakul N; Leelaudomlipi S
Biomed Res Int; 2015; 2015():381602. PubMed ID: 25695068
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value and underlying mechanism of KIAA0101 in hepatocellular carcinoma: database mining and co-expression analysis.
Xu W; Wang X; Wu X; Yu S; Xiong J; Sang X; Zheng Y; Zhang Z
Aging (Albany NY); 2020 Aug; 12(16):16420-16436. PubMed ID: 32855364
[TBL] [Abstract][Full Text] [Related]
6. Variant 2 of KIAA0101, antagonizing its oncogenic variant 1, might be a potential therapeutic strategy in hepatocellular carcinoma.
Liu L; Liu Y; Chen X; Wang M; Zhou Y; Zhou P; Li W; Zhu F
Oncotarget; 2017 Jul; 8(27):43990-44003. PubMed ID: 28410205
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of KIAA0101 predicts high stage, early tumor recurrence, and poor prognosis of hepatocellular carcinoma.
Yuan RH; Jeng YM; Pan HW; Hu FC; Lai PL; Lee PH; Hsu HC
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5368-76. PubMed ID: 17875765
[TBL] [Abstract][Full Text] [Related]
8. Decreased levels of nitric oxide production and nitric oxide synthase-2 expression are associated with the development and metastasis of hepatocellular carcinoma.
Zhou L; Wang Y; Tian DA; Yang J; Yang YZ
Mol Med Rep; 2012 Dec; 6(6):1261-6. PubMed ID: 23007408
[TBL] [Abstract][Full Text] [Related]
9. KIAA0101 (OEACT-1), an expressionally down-regulated and growth-inhibitory gene in human hepatocellular carcinoma.
Guo M; Li J; Wan D; Gu J
BMC Cancer; 2006 Apr; 6():109. PubMed ID: 16646990
[TBL] [Abstract][Full Text] [Related]
10. Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis.
Chen DB; Zhao YJ; Wang XY; Liao WJ; Chen P; Deng KJ; Cong X; Fei R; Wu X; Shao QX; Wei L; Xie XW; Chen HS
Chin Med J (Engl); 2019 Jul; 132(13):1572-1581. PubMed ID: 31188160
[TBL] [Abstract][Full Text] [Related]
11. SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway.
Zhao J; Wozniak A; Adams A; Cox J; Vittal A; Voss J; Bridges B; Weinman SA; Li Z
J Exp Clin Cancer Res; 2019 Jun; 38(1):252. PubMed ID: 31196136
[TBL] [Abstract][Full Text] [Related]
12. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
Dong-Dong L; Xi-Ran Z
Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
[TBL] [Abstract][Full Text] [Related]
13. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
[TBL] [Abstract][Full Text] [Related]
14. Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma.
Qin HX; Nan KJ; Yang G; Jing Z; Ruan ZP; Li CL; Xu R; Guo H; Sui CG; Wei YC
World J Gastroenterol; 2005 May; 11(18):2709-13. PubMed ID: 15884108
[TBL] [Abstract][Full Text] [Related]
15. ALK gene copy number gain and its clinical significance in hepatocellular carcinoma.
Jia SW; Fu S; Wang F; Shao Q; Huang HB; Shao JY
World J Gastroenterol; 2014 Jan; 20(1):183-92. PubMed ID: 24415871
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
17. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
[TBL] [Abstract][Full Text] [Related]
18.
Hu S; Zeng W; Zhang W; Xu J; Yu D; Peng J; Wei Y
Aging (Albany NY); 2020 Nov; 13(1):301-339. PubMed ID: 33231570
[TBL] [Abstract][Full Text] [Related]
19. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ
BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis reveals novel driver genes and molecular subclasses of hepatocellular carcinoma.
Yang L; Zhang Z; Sun Y; Pang S; Yao Q; Lin P; Cheng J; Li J; Ding G; Hui L; Li Y; Li H
Aging (Albany NY); 2020 Nov; 12(23):23849-23871. PubMed ID: 33221766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
